| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2015 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 5,000 | $6.00 | $30,000.00 | -0.7% | |
| Sep 9, 2015 | BIO Bio-Rad Laboratories, Inc. | Hutton Ronald W | Vice President And Treasurer | Sell | 67 | $139.01 | $9,313.67 | -3.1% | |
| Sep 9, 2015 | BIO Bio-Rad Laboratories, Inc. | Magni Giovanni | EVP, Chief Strategy Officer | Sell | 91 | $139.01 | $12,649.91 | -0.8% | |
| Sep 9, 2015 | BIO Bio-Rad Laboratories, Inc. | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 97 | $139.01 | $13,483.97 | -4.1% | |
| Sep 9, 2015 | BIO Bio-Rad Laboratories, Inc. | Stark James R | VP, Corporate Controller | Sell | 76 | $139.01 | $10,564.76 | -38.0% | |
| Sep 9, 2015 | BIO Bio-Rad Laboratories, Inc. | Schwartz Norman D | Chairman, President, And CEO | Sell | 1,255 | $138.60 | $173,945.01 | -0.3% | |
| Sep 9, 2015 | BIO Bio-Rad Laboratories, Inc. | Hertia John | Executive Vice President | Sell | 227 | $139.01 | $31,555.27 | -2.3% | |
| Sep 9, 2015 | BIO Bio-Rad Laboratories, Inc. | Tsingos Christine A | EVP And CFO | Sell | 76 | $139.01 | $10,564.76 | -1.8% | |
| Sep 9, 2015 | BIO Bio-Rad Laboratories, Inc. | Hall Shannon | Executive Vice President | Sell | 84 | $139.01 | $11,676.84 | -6.4% | |
| Sep 4, 2015 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 4,200 | $6.00 | $25,184.00 | -0.3% | |
| Sep 3, 2015 | RVTY Revvity, Inc. | Sicchitano Kenton J54 | Director | Sell | 12,586 | $47.88 | $602,630.27 | -23.1% | |
| Sep 3, 2015 | MYGN Myriad Genetics Inc | King Gary A. | Exec. VP International Ops | Sell | 25,438 | $39.41 | $1,002,511.58 | -33.1% | |
| Sep 2, 2015 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 6,500 | $6.04 | $39,265.00 | -0.3% | |
| Sep 2, 2015 | MYGN Myriad Genetics Inc | King Gary A. | Exec. VP International Ops | Sell | 15,000 | $38.23 | $573,450.00 | -22.6% | |
| Sep 2, 2015 | IQV Iqvia Holdings Inc. | Williams Charles Edward | Sr VP And Controller | Sell | 5,000 | $72.43 | $362,150.00 | -70.7% | |
| Aug 31, 2015 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 300 | $6.24 | $1,872.00 | - | |
| Aug 28, 2015 | MYGN Myriad Genetics Inc | King Gary A. | Exec. VP International Ops | Sell | 30,000 | $35.73 | $1,071,900.00 | -36.8% | |
| Aug 28, 2015 | TMO Thermo Fisher Scientific Inc. | Malus Alan J | Executive Vice President | Sell | 4,557 | $127.55 | $581,245.35 | -9.0% | |
| Aug 26, 2015 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 11,000 | $6.20 | $68,170.00 | -0.5% | |
| Aug 25, 2015 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 7,126 | $6.08 | $43,347.34 | -0.5% | |
| Aug 21, 2015 | NOTV Inotiv, Inc. | Dougherty Connie Leigh | VP, Business Development | Buy | 6,900 | $1.42 | $9,798.00 | New | |
| Aug 19, 2015 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 1,600 | $7.22 | $11,552.00 | -0.2% | |
| Aug 17, 2015 | CRL Charles River Laboratories International, Inc. | Ackerman Thomas F | Senior Financial Advisor | Sell | 5,000 | $75.53 | $377,664.76 | -0.2% | |
| Aug 17, 2015 | WST West Pharmaceutical Services Inc | Federici William J | Sr. VP &CFO | Sell | 52,678 | $59.72 | $3,146,125.07 | -20.5% | |
| Aug 13, 2015 | BIO Bio-Rad Laboratories, Inc. | Goetz John | EVP, Chief Operating Officer | Sell | 4,558 | $147.21 | $670,984.88 | -4.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.